Partnerships & Collaborations
Our mission is to reduce the burden of intravitreal injections for patients.
Partnerships are at the core of our strategy to achieve this.
Our platform improves the longevity of injectable ophthalmology products, where proteins or peptides are delivered intravitreally.
We focus on products approved or currently in development to treat neovascular and degenerative retinal diseases, such as Geographic Atrophy (GA)